We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Amgen Inc | NASDAQ:AMGN | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.9615 | -0.35% | 276.4085 | 276.39 | 276.53 | 278.515 | 275.10 | 277.69 | 340,295 | 15:21:05 |
From May 2022 to May 2024
10:36 ET -- Amgen Inc. is one of the most talked about companies in the U.S. across all news items in the last 12 hours, according to Factiva data. The biotechnology company has agreed to pay nearly $28 billion to buy Horizon Therapeutics PLC in the biggest healthcare deal of the year. Amgen shares are down 1.3%. Dow Jones & Co. owns Factiva. (colin.kellaher@wsj.com)
(END) Dow Jones Newswires
December 12, 2022 10:52 ET (15:52 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
1 Year Amgen Chart |
1 Month Amgen Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
